Healthcare

Charterhouse enters Italian market, buys Doc Generici

Charterhouse Capital Partners has wholly acquired Italian pharmaceutical firm Doc Generici, marking the GP’s first transaction in the Italian market, according to reports.

Southern Europe unquote | 22 May 2013 | secure

Phagenesis expands series-B round to $17m

Phagenisis has extended its series-B funding round to reach $17m.

UK unquote | 22 May 2013 | secure

HealthCap, Industrifonden et al. back Oncopeptides

HealthCap, Industrifonden and other investors have taken part in a series-A financing round for Swedish medical start-up Oncopeptides AB.

Nordic unquote | 22 May 2013 | secure

Mig et al. add €9.5m to SuppreMol series-D round

Mig AG and BioMed Partners have injected an additional €9.5m into Germany-based SuppreMol alongside a number of other backers in an extension of the company’s series-D funding round.......

DACH unquote | 22 May 2013 | secure

3i reaps 2.3x on Xellia exit

3i has agreed to sell Xellia Pharmaceuticals AS, a Norwegian speciality pharmaceutical group, to Novo AS for £460m.

Nordic unquote | 21 May 2013 | secure

Merck increases MS Ventures commitment

Merck Group has topped up its strategic venture capital fund MS Ventures with an additional €60m commitment and created an investment affiliate to specifically manage the vehicle.

DACH unquote | 17 May 2013 | secure

SEP backs €16m Mister Spex round

Scottish Equity Partners (SEP) has joined a €16m round of funding for German online optician Mister Spex.

DACH unquote | 14 May 2013 | secure

Caixa Capital Risc leads €1.1m round for iMicroQ

Caixa Capital Risc has led a €1.1m funding round for Spanish biotech firm iMicroQ.

Southern Europe unquote | 10 May 2013 | secure

Cardio3 raises €19m in new funding round

Belgian biopharmaceutical company Cardio3 Biosciences has completed a funding round that saw previous investors inject €7m in new equity alongside the conversion of €12m in existing......

Benelux unquote | 09 May 2013 | secure

Omega Funds leads $10m round for SpineVision

Omega Funds has led a $10m funding round for French medical devices provider SpineVision, which also included investments from two other new backers.

France unquote | 08 May 2013 | secure

Kurma leads €17m series-B round for Stat Diagnostica

Kurma Life Sciences Partners has led a €17m series-B round for Spanish medical diagnostics company Stat Diagnostica.

Southern Europe unquote | 07 May 2013 | secure

Novo AS et al. round up €141m Symphogen financing

Novo AS, PKA and Danica Pension have provided Danish biopharmaceutical company Symphogen with a further €41m, rounding up a €141m funding round for the business.

Nordic unquote | 02 May 2013 | secure
Swedish GPs cash in on pharmaceutical reform

Swedish GPs cash in on pharmaceutical reform

Since the Swedish pharmaceutical sector was reformed four years ago, private equity firms have piled into the industry. Today, those investments are demonstrating impressive returns.

unquote | 02 May 2013 | secure

Novartis Venture et al. in €33m series-C round for Opsona

A consortium of new and existing investors has injected €33m into Irish immunology drug development company Opsona Therapeutics as part of a series-C funding round.

UK unquote | 30 Apr 2013 | secure

LBO France's Médi-Partenaires hopes to raise €385m on high-yield market

Médi-Partenaires, a French chain of clinics backed by LBO France and Equistone, is understood to be aiming to raise €385m on the high-yield bond market.

France unquote | 26 Apr 2013 | secure
Page 1 of 77

Regions

Search unquote.com

Events

event logo

unquote" British Private Equity Awards 2013

The next unquote British Private Equity Awards will take place on 3rd October 2013 in London....

Updating your subscription status Loading

Digital Editions

Unquote Analysis DACH Cover

DACH unquote” May 2013

CVC’s €3bn buy-back of Ista in April caused much excitement for German private equity in 2013, though a deeper look at the figures......

More digital editions

Unquote Analysis France Cover

France unquote” May 2013

“Some key ideas are currently gaining ground,” said Afic chairman Louis Godron at the association’s annual conference in Paris......

More digital editions

Unquote Analysis UK Cover

UK & Ireland unquote” May 2013

The UK & Ireland’s first quarter activity levels are at their lowest level for the past five years, according to the latest research......

More digital editions

Unquote Analysis Nordics Cover

Nordic unquote" May 2013

For almost 40 years, Sweden was one of the few countries in the world where private retail of pharmaceuticals was banned.

More digital editions

Unquote Analysis SE Cover

Southern Europe unquote” May 2013

Italian businesses are struggling. In the first quarter of the year, 4,218 Italian firms went bankrupt according to financial newspaper......

More digital editions

Unquote Analysis CEE cover

CEE unquote” April 2013

It’s official: Central and Eastern Europe is unsexy. It is the least desirable geography for family offices to invest in, according......

More digital editions

Unquote Analysis Benelux Cover

Benelux unquote" April 2013

Exits have dominated the Benelux market in the past month, but the disposals were not all good news for private equity in the region.......

More digital editions

Events

event

unquote" British Private Equity Awards 2013

Date: 03 Oct 2013
Location: London, UK
event

unquote" DACH Private Equity Forum

Date: 10 Oct 2013
Location: Munich, Germany
event

unquote" Italia Private Equity Forum

Date: 12 Nov 2013
Location: Milan, Italy

Email Alerts